Difference between revisions of "About-cancer/treatment/drugs/stomach"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Drugs Approved for Stomach (Gastric) Cancer == | + | == Drugs Approved for Stomach (Gastric) Cancer == <!--T:1--> |
| + | <!--T:2--> | ||
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for stomach (gastric) cancer. The list includes generic and brand names. This page also lists common drug combinations used in stomach (gastric) cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used. | This page lists cancer drugs approved by the Food and Drug Administration (FDA) for stomach (gastric) cancer. The list includes generic and brand names. This page also lists common drug combinations used in stomach (gastric) cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used. | ||
| + | <!--T:3--> | ||
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in stomach (gastric) cancer that are not listed here. | The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in stomach (gastric) cancer that are not listed here. | ||
| + | <!--T:4--> | ||
'''ON THIS PAGE''' | '''ON THIS PAGE''' | ||
| + | <!--T:5--> | ||
*Drugs Approved for Stomach (Gastric) Cancer | *Drugs Approved for Stomach (Gastric) Cancer | ||
| + | <!--T:6--> | ||
*Drug Combinations Used in Stomach (Gastric) Cancer | *Drug Combinations Used in Stomach (Gastric) Cancer | ||
| + | <!--T:7--> | ||
*Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors | *Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors | ||
| + | <!--T:8--> | ||
'''Drugs Approved for Stomach (Gastric) Cancer''' | '''Drugs Approved for Stomach (Gastric) Cancer''' | ||
| + | <!--T:9--> | ||
Cyramza (Ramucirumab) | Cyramza (Ramucirumab) | ||
| + | <!--T:10--> | ||
Docetaxel | Docetaxel | ||
| + | <!--T:11--> | ||
Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | ||
| + | <!--T:12--> | ||
5-FU (Fluorouracil Injection) | 5-FU (Fluorouracil Injection) | ||
| + | <!--T:13--> | ||
Fluorouracil Injection | Fluorouracil Injection | ||
| + | <!--T:14--> | ||
Herceptin (Trastuzumab) | Herceptin (Trastuzumab) | ||
| + | <!--T:15--> | ||
Keytruda (Pembrolizumab) | Keytruda (Pembrolizumab) | ||
| + | <!--T:16--> | ||
Lonsurf (Trifluridine and Tipiracil Hydrochloride) | Lonsurf (Trifluridine and Tipiracil Hydrochloride) | ||
| + | <!--T:17--> | ||
Mitomycin C | Mitomycin C | ||
| + | <!--T:18--> | ||
Pembrolizumab | Pembrolizumab | ||
| + | <!--T:19--> | ||
Ramucirumab | Ramucirumab | ||
| + | <!--T:20--> | ||
Taxotere (Docetaxel) | Taxotere (Docetaxel) | ||
| + | <!--T:21--> | ||
Trastuzumab | Trastuzumab | ||
| + | <!--T:22--> | ||
Trifluridine and Tipiracil Hydrochloride | Trifluridine and Tipiracil Hydrochloride | ||
| + | <!--T:23--> | ||
'''Drug Combinations Used in Stomach (Gastric) Cancer''' | '''Drug Combinations Used in Stomach (Gastric) Cancer''' | ||
| + | <!--T:24--> | ||
FU-LV | FU-LV | ||
| + | <!--T:25--> | ||
TPF | TPF | ||
| + | <!--T:26--> | ||
XELIRI | XELIRI | ||
| + | <!--T:27--> | ||
'''Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors''' | '''Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors''' | ||
| + | <!--T:28--> | ||
Afinitor (Everolimus) | Afinitor (Everolimus) | ||
| + | <!--T:29--> | ||
Afinitor Disperz (Everolimus) | Afinitor Disperz (Everolimus) | ||
| + | <!--T:30--> | ||
Everolimus | Everolimus | ||
| + | <!--T:31--> | ||
Lanreotide Acetate | Lanreotide Acetate | ||
| + | <!--T:32--> | ||
Somatuline Depot (Lanreotide Acetate) | Somatuline Depot (Lanreotide Acetate) | ||
</translate> | </translate> | ||
Latest revision as of 21:39, 29 October 2019
Drugs Approved for Stomach (Gastric) Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for stomach (gastric) cancer. The list includes generic and brand names. This page also lists common drug combinations used in stomach (gastric) cancer. The individual drugs in the combinations are FDA-approved. However, the drug combinations themselves usually are not approved, although they are widely used.
The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in stomach (gastric) cancer that are not listed here.
ON THIS PAGE
- Drugs Approved for Stomach (Gastric) Cancer
- Drug Combinations Used in Stomach (Gastric) Cancer
- Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
Drugs Approved for Stomach (Gastric) Cancer
Cyramza (Ramucirumab)
Docetaxel
Doxorubicin Hydrochloride
5-FU (Fluorouracil Injection)
Fluorouracil Injection
Herceptin (Trastuzumab)
Keytruda (Pembrolizumab)
Lonsurf (Trifluridine and Tipiracil Hydrochloride)
Mitomycin C
Pembrolizumab
Ramucirumab
Taxotere (Docetaxel)
Trastuzumab
Trifluridine and Tipiracil Hydrochloride
Drug Combinations Used in Stomach (Gastric) Cancer
FU-LV
TPF
XELIRI
Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
Afinitor (Everolimus)
Afinitor Disperz (Everolimus)
Everolimus
Lanreotide Acetate
Somatuline Depot (Lanreotide Acetate)
